Publications

Found 1 results
Filters: Author is D.Y. Zhong  [Clear All Filters]
2012
D. Y. Zhong, Chu, H. Y., Wang, M. L., Ma, L., Shi, D. N., and Zhang, Z. D., Meta-analysis demonstrates lack of association of the hOGG1 Ser326Cys polymorphism with bladder cancer risk, vol. 11, pp. 3490-3496, 2012.
Arizono K, Osada Y and Kuroda Y (2008). DNA repair gene hOGG1 codon 326 and XRCC1 codon 399 polymorphisms and bladder cancer risk in a Japanese population. Jpn. J. Clin. Oncol. 38: 186-191. http://dx.doi.org/10.1093/jjco/hym176 PMid:18272472   Audebert M, Radicella JP and Dizdaroglu M (2000). Effect of single mutations in the OGG1 gene found in human tumors on the substrate specificity of the Ogg1 protein. Nucleic Acids Res. 28: 2672-2678. http://dx.doi.org/10.1093/nar/28.14.2672 PMid:10908322 PMCid:102664   Blons H, Radicella JP, Laccourreye O, Brasnu D, et al. (1999). Frequent allelic loss at chromosome 3p distinct from genetic alterations of the 8-oxoguanine DNA glycosylase 1 gene in head and neck cancer. Mol. Carcinog. 26: 254- 260. http://dx.doi.org/10.1002/(SICI)1098-2744(199912)26:4<254::AID-MC4>3.0.CO;2-D   Chen SK, Hsieh WA, Tsai MH, Chen CC, et al. (2003). Age-associated decrease of oxidative repair enzymes, human 8-oxoguanine DNA glycosylases (hOgg1), in human aging. J. Radiat. Res. 44: 31-35. http://dx.doi.org/10.1269/jrr.44.31   Egger M, Davey SG, Schneider M and Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. http://dx.doi.org/10.1136/bmj.315.7109.629 PMid:9310563 PMCid:2127453   Figueroa JD, Malats N, Real FX, Silverman D, et al. (2007). Genetic variation in the base excision repair pathway and bladder cancer risk. Hum. Genet. 121: 233-242. http://dx.doi.org/10.1007/s00439-006-0294-y PMid:17203305   Gangwar R, Ahirwar D, Mandhani A and Mittal RD (2009). Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population? Mutat. Res. 680: 56-63. http://dx.doi.org/10.1016/j.mrgentox.2009.09.008 PMid:19815090   Hill JW and Evans MK (2007). A novel R229Q OGG1 polymorphism results in a thermolabile enzyme that sensitizes KG-1 leukemia cells to DNA damaging agents. Cancer Detect. Prev. 31: 237-243. http://dx.doi.org/10.1016/j.cdp.2007.05.001 PMid:17651912 PMCid:2699023   Huang M, Dinney CP, Lin X, Lin J, et al. (2007). High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility. Cancer Epidemiol. Biomark. Prev. 16: 84-91. http://dx.doi.org/10.1158/1055-9965.EPI-06-0712 PMid:17220334   Ioannidis JP, Ntzani EE, Trikalinos TA and Contopoulos-Ioannidis DG (2001). Replication validity of genetic association studies. Nat. Genet. 29: 306-309. http://dx.doi.org/10.1038/ng749 PMid:11600885   Kakehi Y, Hirao Y, Kim WJ, Ozono S, et al. (2010). Bladder Cancer Working Group report. Jpn. J. Clin. Oncol. 40 (Suppl 1): i57-i64. http://dx.doi.org/10.1093/jjco/hyq128 PMid:20870921   Karahalil B, Kocabas NA and Ozcelik T (2006). DNA repair gene polymorphisms and bladder cancer susceptibility in a Turkish population. Anticancer Res. 26: 4955-4958. PMid:17214369   Kim EJ, Jeong P, Quan C, Kim J, et al. (2005). Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer. Urology 65: 70-75. http://dx.doi.org/10.1016/j.urology.2004.08.005 PMid:15667866   Kohno T, Shinmura K, Tosaka M, Tani M, et al. (1998). Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 16: 3219-3225. http://dx.doi.org/10.1038/sj.onc.1201872 PMid:9681819   Lau J, Ioannidis JP and Schmid CH (1997). Quantitative synthesis in systematic reviews. Ann. Intern. Med. 127: 820-826. PMid:9382404   Luna L, Rolseth V, Hildrestrand GA, Otterlei M, et al. (2005). Dynamic relocalization of hOGG1 during the cell cycle is disrupted in cells harbouring the hOGG1-Cys326 polymorphic variant. Nucleic Acids Res. 33: 1813-1824. http://dx.doi.org/10.1093/nar/gki325 PMid:15800211 PMCid:1072800   Moss GW (1971). The Second World Conference on Smoking and Health. London, England, September 1971. Can. J. Public Health 62: 537-541. PMid:4399971   Munafo M (2004). Replication validity of genetic association studies of smoking behavior: what can meta-analytic techniques offer? Nicotine Tob. Res. 6: 381-382. http://dx.doi.org/10.1080/14622200410001676369 PMid:15203812   Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, Steineck G, et al. (2007). Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J. Urol. 25: 285-295. http://dx.doi.org/10.1007/s00345-007-0168-5 PMid:17530260   Narter KF, Ergen A, Agachan B, Gormus U, et al. (2009). Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1). Anticancer Res. 29: 1389-1393. PMid:19414392   Reulen RC, Kellen E, Buntinx F, Brinkman M, et al. (2008). A meta-analysis on the association between bladder cancer and occupation. Scand. J. Urol. Nephrol. (Suppl) 64-78. http://dx.doi.org/10.1080/03008880802325192 PMid:18815919   Tarng DC, Tsai TJ, Chen WT, Liu TY, et al. (2001). Effect of human OGG1 1245C→G gene polymorphism on 8-hydroxy- 2'-deoxyguanosine levels of leukocyte DNA among patients undergoing chronic hemodialysis. J. Am. Soc. Nephrol. 12: 2338-2347. PMid:11675410   Weiss JM, Goode EL, Ladiges WC and Ulrich CM (2005). Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol. Carcinog. 42: 127-141. http://dx.doi.org/10.1002/mc.20067 PMid:15584022   Wu X, Gu J, Grossman HB, Amos CI, et al. (2006). Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am. J. Hum. Genet. 78: 464-479. http://dx.doi.org/10.1086/500848 PMid:16465622 PMCid:1380289   Wu X, Ros MM, Gu J and Kiemeney L (2008). Epidemiology and genetic susceptibility to bladder cancer. BJU Int. 102: 1207-1215. http://dx.doi.org/10.1111/j.1464-410X.2008.07961.x PMid:19035883   Yuan W, Xu L, Feng Y, Yang Y, et al. (2010). The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res. Treat. 122: 835-842. http://dx.doi.org/10.1007/s10549-009-0722-5 PMid:20058067   Yun SJ, Ha YS, Chae Y, Kim JS, et al. (2012). The hOGG1 mutant genotype is associated with prostate cancer susceptibility and aggressive clinicopathological characteristics in the Korean population. Ann. Oncol. 23: 401-405. http://dx.doi.org/10.1093/annonc/mdr115 PMid:21515665   Zeegers MP, Tan FE, Dorant E and van Den Brandt PA (2000). The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 89: 630-639. http://dx.doi.org/10.1002/1097-0142(20000801)89:3<630::AID-CNCR19>3.0.CO;2-Q   Zhang Y, He BS, Pan YQ, Xu YQ, et al. (2011). Association of OGG1 Ser326Cys polymorphism with colorectal cancer risk: a meta-analysis. Int. J. Colorectal Dis. 26: 1525-1530. http://dx.doi.org/10.1007/s00384-011-1258-9 PMid:21695387   Zintzaras E and Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet. Epidemiol. 28: 123-137. http://dx.doi.org/10.1002/gepi.20048 PMid:15593093